Record quarterly results with strong revenue and earnings growth, driven by high-quality clinical outcomes, robust acquisition activity, and improved operational metrics. Raised 2026 guidance reflects confidence in continued expansion and stable reimbursement, supported by strong liquidity and disciplined capital allocation.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.